Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices

Transplantation

Volumn 73, Issue 1, 2002, Pages 63-67

  Singh, Nina ^a   Wagener, Marilyn M ^b   Marino, Ignazio R ^b   Gayowski, Timothy ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SURGICAL TECHNIQUE; TRANSFUSION;

EID: 0037080599     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200201150-00011     Document Type: Article

References (25)

1. Risk factors for systemic fungal infections in liver transplant recipients
2. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients
3. Invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppressive agent
4. Risk factors for invasive fungal infections complicating orthotopic liver transplantation
5. Infections after liver transplantation, an analysis of 101 consecutive cases
6. Clinical spectrum of fungal infections after orthotopic liver transplantation
7. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation
8. Fungus infections after liver transplantation
9. Fungal infections in liver transplant recipients
10. Candida infection in pediatric liver transplant recipients
11. Epidemiology of fungal infections in hematopoietic stem cell transplant recipients in the 1990's
12. Aspergillosis: An increasing problem in tertiary care hospitals?
13. Trends in postmortem epidemiology of invasive fungal infections at a university hospital
14. Changing spectrum of invasive candidiasis and its therapeutic implications
15. Effect of fluconazole administration in critically ill patients
16. Liver transplantation: Current status and novel approaches to liver replacement
17. Orthotopic liver transplantation in high risk patients: Risk factors associated with mortality and infectious morbidity
18. Infectious Complications occurring in liver transplant recipients receiving mycophenolate mofetil
19. High-dose ayclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial
20. Billary reconstruction without T tubes or stents in liver transplantation: Report of 502 consecutive cases
21. Primary liver transplantation without transfusion of red blood cells
22. The independent role of CMV as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
23. Invasive mold infections in allogeneic bone marrow transplant recipients
24. Emerging trends in invasive mold infections in organ transplant recipients
25. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring replacement therapy